SC 13D

Company

Nuvectis Pharma, Inc.

Filed

March 28, 2022

Accession Number

0001104659-22-038886

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →